It is also critical for DNA synthesis, which creates the blueprint for all our genes
Women undergoing this treatment have reported not only weight loss but also improvements in menstrual cycle regularity, which can significantly enhance their quality of life
Administration of LPS, an endotoxin derived from Gram-negative bacteria that activates innate immunity and increases proinflammatory cytokines such as TNF-, IL-6, and IL-1, elevates circulating GLP-1 within 3 hours in mice and humans (57)
Cell 187 , 764781 (2024)
Excision also has the advantage over topical treatments of being a one-off treatment that does not rely on patients adhering to a dosing regimen
Chapters: 00:00 Intro & Paul Bakhtiar Returns 03:15 Peptide Sciences Shutdown 08:37 Peptide Regulations Changing 11:27 Telehealth vs Research Peptides 13:33 Retatrutide & Big Pharma Control 21:11 Peptides Returning to Compounding 27:31 Doctors Learning About Peptides 32:43 New Peptide FLGR-24 37:48 Pauls Personal Peptide Stack 39:31 Dihexa & Brain Health 45:09 Peptides vs Steroids 47:48 Teen Athletes & Peptide Use 52:04 Thymosin Alpha-1 & Cancer Research 54:00 Warrior Platform Announcement We cover: What actually happened to Peptide Sciences The sudden shutdown that shocked the peptide community Alleged issues with offshore credit card processing Why it likely had nothing to do with peptides themselves How banking restrictions affect peptide companies Why peptide companies struggle with payment processors Banks labeling peptide businesses high risk Why companies rely on ACH, Zelle, crypto, and other payment systems How frozen reserves and chargeback policies impact companies Why payment limitations are common across the peptide industry New regulatory shifts in the peptide world 1419 peptides potentially moving into Category 1 compounding What this means for doctors and compounding pharmacies How prescription access could change availability and pricing The difference between FDA approval and compounding eligibility Retatrutide and the GLP-1 landscape Why Retatrutide is projected to be a trillion-dollar compound Eli Lillys push toward full FDA approval How pharmaceutical monopolies affect peptide availability Why research peptide access may shrink as drugs move through approval Why peptides arent always FDA approved Lack of profit incentive for pharmaceutical companies High cost of clinical trials and approval processes Why many effective compounds remain outside the approval pipeline How consumer demand is forcing the medical world to pay attention The growing peptide movement Why patients are bringing peptide discussions to their doctors How education and podcasts are helping drive awareness Why more physicians are starting to research peptides themselves The shift toward preventative and regenerative health The big takeaway: peptides are rapidly evolving, and the demand for these signaling molecules continues to grow as more people discover their potential for healing, longevity, and performance
